Prostate carcinoma
MONDO:0005159A carcinoma that arises from epithelial cells of the prostate gland.
Also known as: carcinoma of prostate, carcinoma of prostate gland, carcinoma of the prostate, prostate carcinoma, prostate gland carcinoma, cancer of prostate, cancer of the prostate, prostate cancer
4033 clinical trials for this condition and its sub-types, 394 tagged with Prostate carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Prostate carcinoma
-
Metastatic prostate carcinoma 670 trials
-
Castration-resistant prostate carcinoma 480 trials
-
Prostate adenocarcinoma 298 trials
2 sub-types
- Prostate adenoid cystic carcinoma 0 trials
- Prostatic acinar adenocarcinoma 0 trials Sub-types →
-
Hormone-resistant prostate carcinoma 30 trials
-
Prostate small cell carcinoma 9 trials
-
Familial prostate carcinoma 0 trials
-
1 sub-type
-
Prostate squamous cell carcinoma 0 trials
1 sub-type
- Adenosquamous prostate carcinoma 0 trials
Most studied deeper sub-types
-
Could a common blood pressure drug help fight prostate cancer?
Disease control Stopped earlyThis pilot trial asks whether propranolol, a drug that blocks stress signals, can influence how prostate cancer cells survive or die. Men with prostate cancer scheduled for surgery will take propranolol before their operation. Researchers will then examine the removed prostate ti…
Phase 2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Could a common diabetes drug shrink prostate tumors?
Disease control Stopped earlyThis early-stage trial is testing whether dapagliflozin (Farxiga), a drug used for diabetes and heart failure, is safe and tolerable when taken for four weeks before prostate removal surgery in men with localized prostate cancer. The study will also look for signs that the drug m…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Cancer drug niraparib tested before prostate surgery – early trial stopped
Disease control Stopped earlyThis phase II trial tested the drug niraparib (Zejula) in 11 men with high-risk prostate cancer that had not spread. All men had specific DNA repair gene mutations. They took niraparib before having their prostate removed surgically. The goal was to see if the drug could eliminat…
Phase 2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Tailored cancer therapy put to the test
Disease control Stopped earlyThis study tested a precision medicine approach for people with advanced cancers like breast, ovarian, pancreatic, prostate, or sarcoma. Researchers used genetic and protein tests to track how the cancer changes and then a team of experts recommended personalized drugs. The goal …
Phase 2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Promising prostate cancer combo study halted early
Disease control Stopped earlyThis study tested whether adding the drug SHR3680 to standard hormone therapy could improve outcomes for men with high-risk prostate cancer before they had surgery to remove the prostate. The trial enrolled 391 participants and aimed to see if the combination could eliminate all …
Phase 3 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Promising combo therapy for aggressive prostate cancer tested before surgery
Disease control Stopped earlyThis study tested whether giving a targeted radiation drug (LuPSMA) with or without an immunotherapy drug (ipilimumab) before prostate removal surgery is safe and feasible for men with very high-risk prostate cancer. Only one participant was enrolled before the study was stopped …
Phase 1/2 • Sponsor: University Hospital, Essen • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo treatment targets returned prostate cancer
Disease control Stopped earlyThis study tested a treatment for prostate cancer that came back after previous radiation. It combined temporary radioactive implants placed in the prostate, daily external radiation to the pelvis for 5 weeks, and 6 months of hormone therapy. The goal was to see if this approach …
Phase 1/2 • Sponsor: Loyola University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New cancer drug trial halted early – what we know
Disease control Stopped earlyThis early-stage trial tested an experimental drug called NUV-868, alone or with other cancer drugs, in 82 adults with advanced solid tumors (including ovarian, pancreatic, prostate, and breast cancers). The goal was to find safe doses and check for early signs of effectiveness. …
Phase 1 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Exercise program targets metabolic risks in cancer survivors
Disease control Stopped earlyThis study looked at whether a specific type of exercise, combining aerobic and resistance training in short bursts, could improve metabolic health in overweight or obese breast and prostate cancer survivors who had finished treatment. The goal was to reduce insulin resistance an…
Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Massage therapy tested as fatigue fix for prostate cancer survivors
Symptom relief Stopped earlyThis phase II trial tested whether Swedish massage can reduce fatigue in men who have had radiation for prostate cancer. The study enrolled 28 men aged 45 and older who reported significant fatigue. Researchers measured fatigue levels and inflammatory markers before and after mas…
Phase 2 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Can a video game teach surgeons to remove prostate cancer?
Knowledge-focused Stopped earlyThis study tested whether an online video simulator helps surgeons learn laparoscopic radical prostatectomy, a surgery for prostate cancer. It enrolled 29 surgeons who were new to the procedure, comparing those who used the simulator to those who did not. The trial was terminated…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Simple urine test could spot prostate cancer early
Knowledge-focused Stopped earlyThis study looked at whether DNA markers found in urine can help detect prostate cancer. Researchers collected urine and prostate fluid samples from 24 men with or suspected of having prostate cancer. The goal was to see how accurate these markers are and to understand patient op…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC